[Examination of Very Long Chain Fatty Acids in Diagnosis of X-linked Adrenoleukodystrophy]
Overview
Authors
Affiliations
X-linked adrenoleukodystrophy (X-ALD) (McKusick 300100) is a relatively common disorder due to activity deficiency of a peroxisomal transporter of very long chain acyl-CoA synthetase it causes accumulation of endogenous and exogenous saturated very long chain fatty acids (VLCFA) in plasma and in all tissues. X-ALD is characterised by phenotypic variability, about 80% of patients present more or less progressive demyelinization and adrenal insufficiency. The remaining patients have isolated adrenocortical insufficiency or are asymptomatic or presymptomatic. The measurement of VLCFA accumulation in plasma using the GC-MS method is the basis of diagnosis of X-ALD. Among 162 plasma samples from patients suspected of X-ALD, only 2 were from patients suspected of adrenomyeloneuropathy (AMN). In the analysed material we identified 13 X-ALD hemizygotes and 7 X-ALD heterozygotes. Twelve patients presented the childhood cerebral form of X-ALD. VLCFA profiles in plasma were analysed in 6 patients who were on a diet and Lorenzo oil.
Barillari M, Karali M, Di Iorio V, Contaldo M, Piccolo V, Esposito M Mol Genet Metab Rep. 2020; 24:100615.
PMID: 32596134 PMC: 7306489. DOI: 10.1016/j.ymgmr.2020.100615.
Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.
Lipinski P, Stawinski P, Rydzanicz M, Wypchlo M, Ploski R, Stradomska T J Appl Genet. 2019; 61(1):87-91.
PMID: 31628608 PMC: 6968987. DOI: 10.1007/s13353-019-00523-w.
Rydzanicz M, Stradomska T, Jurkiewicz E, Jamroz E, Gasperowicz P, Kostrzewa G J Appl Genet. 2017; 58(4):475-480.
PMID: 29047053 DOI: 10.1007/s13353-017-0414-5.
Clinical profile of adrenoleukodysrophy.
Acharya S, Gopal R, Bandgar T, Joshi S, Menon P, Shah N Indian J Pediatr. 2009; 76(10):1045-7.
PMID: 19907937 DOI: 10.1007/s12098-009-0220-0.